Published in
American Society of Hematology, Blood, 23(125), p. 3637-3646, 2015
DOI: 10.1182/blood-2015-02-629683
Links
- ORCID
- American Society of Hematology | PDF
- ORCID
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Modified Ham test for atypical Hemolytic Uremic Syndrome
Journal article published in 2015 by
Eleni Gavriilaki 
,
Xuan Yuan,
Zhaohui Ye,
Alexander J. Ambinder ,
Satish P. Shanbhag,
Michael B. Streiff,
Thomas S. Kickler,
Alison R. Moliterno,
C. John Sperati,
C. John Sperati ,
Robert A. Brodsky
,
Xuan Yuan,
Zhaohui Ye,
Alexander J. Ambinder ,
Satish P. Shanbhag,
Michael B. Streiff,
Thomas S. Kickler,
Alison R. Moliterno,
C. John Sperati,
C. John Sperati ,
Robert A. Brodsky
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points GPI-anchor–deficient cell lines are more vulnerable to complement C5b-9 deposition and cell killing from aHUS serum. PIGA-null reagent cell lines can be used to rapidly and reliably distinguish aHUS from other thrombotic microangiopathies.